Latest News

Cochrane Library health communication priorities

‘Doctors, clinicians and health professionals are not speaking in a voice that can be understood, especially by marginalised groups’. The Cochrane Collaboration is a global, independent, not-for-profit organisation based in Australia, dedicated to producing up-to-date, accurate information about health policy and healthcare. Their high quality reviews are used internationally to deliver best practice, not only […]

Read more

TOPRA launches new Product Information special interest group

Luto’s co-founder and academic advisor, Professor Theo Raynor recently became a member of the newly formed TOPRA group on Product Information launched in November 2016 at a meeting at their office in London, pictured right.  The group will: provide opportunities to share regulatory knowledge relating to product information across the drug product life cycle via TOPRA, collectively voice […]

Read more

Risk Evaluation & Mitigation Strategies Summit 26th and 27th January

We will be attending the 9th Risk Evaluation & Mitigation Strategies Summit in Arlington, Virginia on the 26th and 27th of this month, the same week President Trump will be sworn into office, so it should be an exciting time to be in Washington! REMS 2017 will feature over thirty speakers from industry, patient advocacy […]

Read more

A warm welcome to Irfan Khalid

Please join us in welcoming a new arrival to our team, Irfan Khalid, who started with us in November 2016 as a Project Assistant. We thought we would ask some searching questions to find out what makes Irfan tick. Q: You have a degree in Biomedical Science and a Masters in Cancer Pharmacology, can you […]

Read more

Do the numbers stack up? Getting to the heart of the matter with statins

Professor Theo Raynor, co-founder and academic advisor to Luto Research supported a recently published study by Lead Author Rebecca Dickinson titled, Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs.  The study formed part of Rebecca’s PhD and was co-funded […]

Read more

Pharma and tech create innovative solutions

Verily Life Sciences, an offshoot of Google’s parent company Alphabet, is no stranger to health tech. The company is also known for its ambitious projects, which to date include a smart contact lens to monitor blood sugar levels, and a wearable that aims to detect the early onset of certain cancers. And this year we’ve […]

Read more

Reverse Advent Calendar Appeal 2016

For the majority of people, Christmas is a welcome celebration that is embraced with open arms. However, for others the festive season can be a bleak prospect and many will face waking up on Christmas Day feeling hungry and hopeless. Whilst flicking through Facebook one evening, I came across a post for a reverse advent calendar. […]

Read more

1-7 December 2016 is Crohn’s and Colitis Awareness Week!

Crohn’s and Colitis are often described as the ‘invisible illness’.  Every 30 minutes someone in the UK is diagnosed with Crohn’s disease or Ulcerative Colitis (the two main forms of Irritable Bowel Disease (IBD)).  Our mission is to make health information clear and underline the importance of using medicines properly for people with long-term illnesses. […]

Read more

Taking silliness very seriously – Christmas Jumper Day 2016

On Thursday 15th December my colleagues and I at Luto will be putting on our warmest, wackiest and most wonderful festive woollies to raise money for this year’s Save the Children’s Christmas Jumper Day appeal. Silliness is set to sweep the nation as millions of people up and down the country donate £2 to sport […]

Read more

Why we are using the wrong language

Professor Theo Raynor – Communicating benefit and harm information. Lecture starts at 4:10 on the video clip The EU ‘Risk Communication on Medicines Workshop’ held in Madrid on 16th and 17th June brought together pharmacovigilance and communication experts from national medicines agencies, and representatives from the World Health Organisation, European Medicines Agency, academia, patients, consumers, and […]

Read more

Luto testing feeds into EMA consultation

Prof Theo Raynor, co-founder and academic advisor to Luto Research responded to 2 recent European Medicines Agency consultations – related to the safety monitoring of medicines (called ‘pharmacovigilance’). Both consultations related to the ‘Risk Management Plan’ which companies have to prepare for all licensed medicines. Prof Raynor’s comments relate specifically to the lay summary of […]

Read more

Patient Information Leaflet ‘Shortcomings’ Report Published

European Union guidance on patient information leaflets (PILs) should include more principles of good information design, and allow for more flexibility in the template for such leaflets. In addition, there should be more input from patients through making ‘user testing’ more iterative, and more care is needed when translating tested leaflets, so that the lay […]

Read more

Join us at the DIA Annual EuroMeeting 6th to 8th April in Hamburg

Luto will be exhibiting at the DIA Annual EuroMeeting which brings stakeholders together to collaborate on when, where and how innovation leads to advances in health care product development.   Professor Theo Raynor, Co-founder and Academic Advisor to Luto will be joining the list of expert speakers during the meeting where you can hear his […]

Read more

Luto support development of educational toolbox on medicines R & D

The European Patients’ Academy (EUPATI) today announced the launch of its new online Toolbox on Medicines Research & Development. The toolbox is available to European patient groups, patient advocates and anyone who is interested in learning more about the medicines research and development (R&D) process. It allows users to freely discover, adapt, and share materials. […]

Read more

Join us at Compamed 16th – 19th November in Düsseldorf

Join us at Compamed, the international meeting point for the supplier market of the ‘med-tech’ industry in Düsseldorf this November. Come and say hello and take a break over coffee with us, you’ll find us in hall 8a on stand R21.  You can also recharge your phone and pick up one of our trade fair survival kits! Got a busy schedule? Make sure we don’t miss […]

Read more

Health Literacy, reducing inequalities and universal precautions

The UCL Institute of Health Equity, led by Professor Sir Michael Marmot has produced a practice resource ‘Improving health literacy to reduce health inequalities’. Our co-founder and academic advisor Professor Theo Raynor was one of a number of experts invited to input into the report, and he outlines here the key messages for him from […]

Read more

Luto newsletter – How clear is your health information?

Luto now provides an even stronger service offering so we’ve put together our first newsletter as a way to tell people about our latest developments. In this first edition, we include a case study on our project with Macmillan Cancer Support, to review and refine the charity’s cancer information booklets. We also welcome Steven our new […]

Read more

Because locations MATTER: Luto launches US office

Luto have finally put roots down in the US and opened our first office within the MATTER community. MATTER is an innovative space which brings together entrepreneurs and industry leaders from a range of fields – including healthcare, IT, medical devices, diagnostics and biopharma – who are passionate about creating products and services that advance the healthcare […]

Read more

Expert input to FDA on Risk Evaluation and Mitigation Strategies (REMS)

A key aim of any research should be to have practical impact – Theo Raynor’s 35 years of research into promoting good consumer medicines information has impacted on policy and practice in the UK and the wider European Union, through input into the European Parliament and the European Medicines Agency. This has been both from an […]

Read more

‘It’s all there in black and white’ – or is it? Improving medicines labelling

Research on the labelling of over-the-counter medicines has been published in the international journal ‘Health Expectations’ with the support of Luto. This is the work of PhD candidate Vivien Tong from the University of Sydney – with one of the co-authors being Professor Theo Raynor, co-founder and academic advisor to Luto. The paper described preliminary […]

Read more

Focusing our sights on eye tracking technology

Luto’s new recruits bring with them a wealth of experience in engineering, eye tracking and human factors. Combined with our academic links, this strengthens our service offering within the eye tracking area. Eye tracking adds an extra dimension to our research capabilities and allows clients to understand how people interact with their information materials or […]

Read more

Luto awards winning poster to BHF – Empowering people through film

The PiF conference was a pleasure to attend as usual – enthusiastic speakers and equally enthusiastic delegates. Early on Sue Farringdon mentioned the NHS ‘Five Year Forward View’ and this made me reflect on my personal ’35 Year Backward View’ – of the amazing development of the field of patient information during my professional life. […]

Read more

Increasing use of QR codes for medicine information

As smartphone use continues to increase, access to the internet via a mobile device has overtaken that of desktop PC’s. This means that QR codes now present an opportunity for Pharmaceutical companies to provide patients and health professionals with additional supporting information that they can access electronically anywhere via their smartphone. As a result of an increased […]

Read more

Introducing Steven Daglish: Engineering a course for medical device success

Luto’s latest new recruit Project Manager Steven Daglish is perfectly placed to help ensure that the latest medical devices fully meet the needs and requirements of end users and patients. With a background in engineering and a previous role with a UK charity, Steven has the technical knowledge and expertise to communicate and build upon […]

Read more

Join Luto at the DIA 51st Annual Meeting this June

Luto will be exhibiting at the DIA 51st Annual Meeting in Washington from 15th to 17th June. The team will be delighted to welcome new and existing customers to our stand #1213 (you can find us on the floor plan). The DIA Annual Meeting is the largest multidisciplinary event that brings together a global network of life sciences professionals; helping to […]

Read more

New drug driving law comes into force

From 2 March 2015 there will be a new drug driving law in England and Wales. This means it will be illegal to drive: with certain illegal drugs in your blood, even if you’re not unfit to drive with certain levels of some legal drugs in your blood, if it has affected your driving, or […]

Read more

Join Luto at the DIA Annual Euromeeting and Clinical Forum this April

Luto will be exhibiting at the DIA Annual EuroMeeting and Clinical Forum in Paris from 13th to 15th April. The team will be delighted to welcome new and existing customers to our stand on Level 2 of the Exhibition Hall – Stand 2.D21. Professor Theo Raynor, Co-founder and Academic Advisor to Luto will be joining […]

Read more